These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7180580)

  • 1. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):303-8. PubMed ID: 7180580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
    Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
    Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic value of the serial determination of galactose elimination capacity in chronic active hepatitis].
    Aebli N; Reichen J
    Schweiz Med Wochenschr; 1991 Jun; 121(26):970-6. PubMed ID: 1862313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death.
    Merkel C; Marchesini G; Fabbri A; Bianco S; Bianchi G; Enzo E; Sacerdoti D; Zoli M; Gatta A
    Hepatology; 1996 Oct; 24(4):820-3. PubMed ID: 8855183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
    Merkel C; Gatta A; Zoli M; Bolognesi M; Angeli P; Iervese T; Marchesini G; Ruol A
    Dig Dis Sci; 1991 Sep; 36(9):1197-203. PubMed ID: 1893804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
    Addario L; Scaglione G; Tritto G; Di Costanzo GG; De Luca M; Lampasi F; Galeota Lanza A; Picciotto FP; Tartaglione MT; Utech W; Macr M; Giannelli E; Ascione A
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):713-20. PubMed ID: 16772827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity.
    Marchesini G; Fabbri A; Bugianesi E; Bianchi GP; Marchi E; Zoli M; Pisi E
    Liver; 1990 Apr; 10(2):65-71. PubMed ID: 2352456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.
    Jepsen P; Vilstrup H; Ott P; Keiding S; Andersen PK; Tygstrup N
    BMC Gastroenterol; 2009 Jun; 9():50. PubMed ID: 19566919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis.
    Homann C; Garred P; Graudal N; Hasselqvist P; Christiansen M; Fagerhol MK; Thomsen AC
    Hepatology; 1995 Apr; 21(4):979-85. PubMed ID: 7705809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit].
    Castera L; Pauwels A; Lévy VG
    Gastroenterol Clin Biol; 1996; 20(3):263-8. PubMed ID: 8763065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative liver function tests in donors and recipients of living donor liver transplantation.
    Jochum C; Beste M; Penndorf V; Farahani MS; Testa G; Nadalin S; Malago M; Broelsch CE; Gerken G
    Liver Transpl; 2006 Apr; 12(4):544-9. PubMed ID: 16482561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia induced by fructose load in liver cirrhosis.
    Budillon G; Citarella C; Loguercio C; Nardone G; Sicolo P; Del Vecchio Blanco C
    Ital J Gastroenterol; 1992 Sep; 24(7):373-7. PubMed ID: 1392016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
    Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
    Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in alcoholic liver cirrhosis: prognostic value of portal pressure, size of esophageal varices and biochemical data. Comparison with Child classification.
    Zimmerer J; Haubitz I; Mainos D; Hadass H; Tittor W
    Z Gastroenterol; 1996 Jul; 34(7):421-7. PubMed ID: 8776835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinomas do not compromise quantitative tests of liver function.
    Ganslmayer M; Ocker M; Zopf S; Schuppan D; Hahn EG; Herold C
    Hepatogastroenterology; 2005; 52(63):881-4. PubMed ID: 15966225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.